Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses

BACKGROUND: Chagas disease is the highest impact parasitic disease in Latin America. We have proposed that changes in Trypanosoma cruzi-specific immune responses might serve as surrogate indicators of treatment success. Herein, we addressed in a long-term follow-up study whether cure achieved after...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, María G., Bertocchi, Graciela L., Cooley, Gretchen, Albareda, María C., Viotti, Rodolfo, Perez-Mazliah, Damián E., Lococo, Bruno, Castro Eiro, Melisa, Laucella, Susana A., Tarleton, Rick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851297/
https://www.ncbi.nlm.nih.gov/pubmed/27128444
http://dx.doi.org/10.1371/journal.pntd.0004657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851297/
https://www.ncbi.nlm.nih.gov/pubmed/27128444
http://dx.doi.org/10.1371/journal.pntd.0004657

Ejemplares similares